Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $44

Benzinga · 3d ago
Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $52 to $44.